-
Miransertib is an orally active, selective and allosteric Akt inhibitor. Miransertib is also a potent the AKT1-E17K mutant protein inhibitor.
Categories
Others
Archives
- April 2021 (1)
Thanks, your subscription has been confirmed. You will hear from us soon.
Submission failed, please try again later.
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.